Paion Competitors and Similar CompaniesClear all
Paion's competitors and similar companies include Array BioPharma.
 Paion PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | |
Founding Date | Founding Date 2000 | Founding Date 1998 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Aachen, DE HQ Odense, DK Hoofddorp, NL Richmond, GB | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US |
Employees | Employees 3218% decrease | Employees 110 |
Financial | ||
Revenue (est.) | Revenue (est.) €33.2m (FY, 2022) | Revenue (est.) $173.8m (FY, 2018) |
Cost of goods | Cost of goods €382k (FY, 2022) | Cost of goods $59.4m (FY, 2018) |
Gross profit | Gross profit €33.4m (FY, 2022) | Gross profit $114.4m (FY, 2018) |
Net income | Net income (€579k) (FY, 2022) | Net income ($147.7m) (FY, 2018) |
For sources of this data, please see the company profile
View Company Profiles
Array BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company